glp-1 kidney news Receptor Agonists and Diabetic Disease: A Call of Attention to Nephrologists Potential kidney-protective and other effects

Instant PDF you can print or keep on your phone

Dihexa is not FDA-approved for any indication and has no published human safety data

None of these platforms is risk-free the boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies, and GLP-1 medications carry well-documented GI side effects (nausea, vomiting, diarrhea, constipation) plus less-common documented events including pancreatitis, gallbladder disease, and acute kidney injury

Another mechanism that may contribute to the antioxidant activity of phenolic compounds is their ability to chelate redox active metal ions, such as iron, cobalt, manganese, or copper, thus preventing reactions catalyzed by these ions that lead to the formation of oxidative species that can generate oxidative damage at different cellular levels